We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 4,297

Guest Post - Eighth Circuit FINALLY Hears Litigation Tourism Issue
  • Reed Smith LLP
  • USA
  • April 18 2017

Today’s guest post is from friend-of-the-blog Sarah Bunce, a partner at Tucker Ellis. It’s about the 8th Circuit finally having before it aspects of


Vast - Or at Least Half-Vast - Conspiracy Claim Dismissed
  • Reed Smith LLP
  • USA
  • April 17 2017

Imagine a conspiracy so vast that it includes not only your usual plaintiff-side fantasy of the FDA conspiring with a drug company, but also high FDA


Spokeo Dismissals - With Prejudice, Without Prejudice or Something Else?
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • April 14 2017

In the wake of the Supreme Court’s decision in Spokeo, Inc. v. Robins, 136 S. Ct. 1540 (2016), federal courts and litigants have grappled not only


Another One Bites the Dust: Plaintiff’s Causation Expert Excluded in Hernia Mesh Litigation
  • Reed Smith LLP
  • USA
  • April 14 2017

We spent Sunday evening in the familiar confines of a top-notch local professional theatre. The production was a short (80-minute), two-character


Jury Returns Massive Verdict in Hospital Gown Fraud Lawsuit
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • April 13 2017

On Friday, April 8, 2017, a federal jury in California sent shockwaves throughout the healthcare and legal community when it returned a $454 million


The Past, Present, and Future of Government Regulation of Off-Label Communications - Part 1
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • April 13 2017

As 2017 began, FDA appeared poised to implement significant changes to the rules governing off-label communications related to drugs, biologics, and


When Precedents Collide
  • Reed Smith LLP
  • USA
  • April 12 2017

We read Michelle Yeary’s recent post about In re Fosamax Products Liability Litigation, ___ F.3d ___, 2017 WL 1075047 (3d Cir. March 22, 2017), with


April 2017 International Trade Compliance Update
  • Baker McKenzie
  • Canada, European Union, United Kingdom, USA
  • April 12 2017

The WTO announced that WTO members discussed five new or enhanced proposals to advance services negotiations at meetings of the Working Party on


Food & Beverage Litigation Update: Issue 631
  • Shook Hardy & Bacon LLP
  • Canada, European Union, USA
  • April 10 2017

The U.S. Food and Drug Administration (FDA) has announced an extension to its comment periods for information on the use of genome editing


Plaintiffs’ Causation Expert Renounces His Own Conclusions - and Withdraws - in Mirena IIH Litigation
  • Reed Smith LLP
  • USA
  • April 10 2017

We have blogged before about the Mirena IUD litigation. Cases alleging injuries from device migration and uterine perforation were centralized in an